A fannin endoscopes na likitanci na cikin gida, duka na'urorin endoscope masu sassauci da masu tsauri sun daɗe suna mamaye kayayyakin da aka shigo da su daga ƙasashen waje. Duk da haka, tare da ci gaba da inganta ingancin cikin gida da kuma saurin ci gaban maye gurbin shigo da kayayyaki, Sonoscape da Aohua sun yi fice a matsayin kamfanoni masu wakilci a fannin endoscope masu sassauci.
Kasuwar endoscope ta likitanci har yanzu tana ƙarƙashin ikon shigo da kayayyaki daga ƙasashen waje
Tsarin fasaha da tsarin masana'antu na masana'antar endoscope na likitanci ta kasar Sin ya daɗe yana baya ga na ƙasashe masu tasowa, amma kamfanoni da yawa sun sami babban ci gaba a wasu ƙananan sassa, a hankali suna kamawa da samfuran da aka shigo da su daga ƙasashen waje a cikin manyan alamun aiki kamar bayyananniyar hoto da kuma sake fasalin launi. A shekarar 2017, yawan wuraren da masana'antar endoscope na likitanci ta kasar Sin ke zaune ya kai kashi 3.6% kacal, wanda ya karu zuwa kashi 6.9% a shekarar 2021, kuma ana sa ran zai kai kashi 35.2% a shekarar 2030.
Yawan endoscopes na likitanci a cikin gida a China(Shigo da kaya & Na Gida)
Taurin Endoscope: A shekarar 2022, girman kasuwar kasuwar endoscope mai tsauri ta China ya kai kimanin yuan biliyan 9.6, kuma samfuran da aka shigo da su daga ƙasashen waje kamar Karl Storz, Olympus, Stryker, da Wolf sun kai jimillar kashi 73.4% na kasuwar. Kamfanonin cikin gida sun fara aiki a makare, amma kamfanonin cikin gida da Mindray ya wakilta sun tashi da sauri, wanda ya kai kusan kashi 20% na kasuwar.
Flexibe Endoscope: A shekarar 2022, girman kasuwar kasuwar endoscope mai sassauci ta China ya kai kimanin yuan biliyan 7.6, kuma kamfanin Olympus da aka shigo da shi shi kaɗai ne, wanda ya kai kashi 60.40% na kasuwar cikin gida, kuma Fuji ta Japan ta zo ta biyu da kaso 14%. Kamfanonin cikin gida da aka wakiltaSonoscapekuma Aohua ta karya ikon mallakar fasahar ƙasashen waje kuma ta tashi da sauri. A shekarar 2022, Sonoscape ta kasance ta farko a China da hannun jari na 9% da kuma ta uku a kasuwa; Aohua ta kasance ta biyu a China da hannun jari na 5.16% kuma ta biyar a kasuwa.
Matrix ɗin Samfura
Aohua ta mayar da hankali kan na'urorin endoscopes masu sassauci na likitanci da kuma abubuwan da ake amfani da su a waje. Ana amfani da kayayyakinta sosai a sassan asibiti kamar su gastroenterology, maganin numfashi, otolaryngology, likitan mata, da kuma maganin gaggawa.
Kamfanin ya kafa manyan layukan samfura guda huɗu, waɗanda suka haɗa da duban dan tayi, duban dan tayi, tiyatar da ba ta da tasiri sosai, da kuma shiga tsakani a cikin zuciya da jijiyoyin jini. An fara ƙirƙirar tsarin haɓaka layukan samfura da yawa. Daga cikinsu, kasuwancin duban dan tayi ya zama ɗaya daga cikin manyan sassan kasuwancin kamfanin kuma shine babban tushen ci gaban kamfanin. Kasuwancin duban dan tayi na kamfanin ya dogara ne akan endoscopes masu sassauƙa, kuma ya haɗa da abubuwan amfani na ƙarshen endoscopy da endoscopes masu tauri.
Tsarin samfurin Endoscope mai sassauƙa na kowane kamfani
Sonoscape da Aohua sun samar da cikakken tsarin samfura a fannin endoscopes masu laushi, kuma tsarin samfuransu yana kusa da na Olympus, jagoran duniya a fannin endoscopes masu sassauƙa.
Babban samfurin Aohua AQ-300 yana cikin kasuwa mai tsada, AQ-200 mai daidaiton aiki da farashi an yi shi ne don kasuwar matsakaici, kuma samfuran asali kamar AQ-120 da AQ-100 sun dace da kasuwar talakawa.
Samfurin endoscope mai sassauƙa na Sonoscape HD-580 yana cikin kasuwa mai tsada, kuma samfurin da ake sayarwa a yanzu shine HD-550, wanda yake a tsakiya. Yana da wadataccen ajiyar kayayyaki a kasuwannin ƙasa da na tsakiya.
Kwatanta aikin endoscopes na matsakaici da na babban mataki
Kayayyakin endoscope masu inganci na Sonoscape da Aohua sun riga sun haɗu da manyan kamfanoni na duniya a fannoni da dama na aiki. Duk da cewa an tallata samfuran biyu masu inganci a kasuwa na ɗan gajeren lokaci, suna ci gaba da samun ci gaba cikin sauri a kasuwa mai inganci ta hanyar dogaro da inganci mai kyau da kuma aiki mai tsada.
A halin yanzu, kasuwar cikin gida ta Aohua da Sonoscape galibi tana cikin asibitoci na sakandare da ƙananan asibitoci. A lokaci guda, dangane da ƙaddamar da kayayyaki masu inganci, sun mamaye kasuwar manyan kamfanoni sama da matakin jami'a a cikin 'yan shekarun nan, kuma kayayyakinsu sun sami karbuwa sosai a kasuwa. Daga cikinsu, na'urorin endoscope na Sonoscape sun shiga asibitoci na manyan kamfanoni sama da 400 nan da shekarar 2023; Aohua ta dogara ne akan haɓaka tsarin endoscope mai inganci na AQ-300 4K a cikin 2024, kuma an shigar da (gami da tayin da ya yi nasara) asibitoci na manyan kamfanoni 116 a wannan shekarar (an shigar da asibitoci na manyan kamfanoni 73 da 23 a cikin 2023 da 2022 bi da bi).
Kudin shiga na aiki
A cikin 'yan shekarun nan, aikin Sonoscape da Aohua yana ƙaruwa cikin sauri, musamman a cikin kasuwancin da suka shafi endoscopy. Duk da cewa za a sami sauye-sauye a cikin 2024 saboda tasirin manufofin masana'antu, aiwatar da manufofin sabunta kayan aiki na gaba zai ƙara haɓaka dawo da buƙatun kasuwa.
Kudaden shiga na Aohua na endoscopy ya karu daga Yuan miliyan 160 a shekarar 2018 zuwa Yuan miliyan 750 a shekarar 2024. A shekarar 2020, saboda tasirin annobar, kudaden shiga na shekarar sun fadi da kashi 11.6%. Tun bayan fitar da kayayyaki masu inganci a shekarar 2023, ci gaban aiki ya kara karuwa. A shekarar 2024, karuwar ci gaban ta ragu saboda tasirin manufofin da suka shafi na'urorin likitanci na cikin gida.
Jimillar kudaden shigar da kamfanin Sonoscape Medical ya samu ya karu daga yuan biliyan 1.23 a shekarar 2018 zuwa yuan biliyan 2.014 a shekarar 2024. Daga cikinsu, kudaden shigar da kamfanonin da suka shafi endoscopy suka samu ya karu daga yuan miliyan 150 a shekarar 2018 zuwa yuan miliyan 800 a shekarar 2024. Ko da a lokacin da annobar ta barke a shekarar 2020, har yanzu ta samu wani ci gaba, amma a karkashin tasirin manufofin da suka shafi na'urorin likitanci a shekarar 2024, kasuwancin da suka shafi endoscopy ya ragu kadan.
Dangane da cikakken kuɗin shiga na kamfanin, jimillar yawan kasuwancin Sonoscape ya fi na Aohua yawa, amma ƙimar ci gabansa ya ɗan yi ƙasa da na Aohua. Ga kasuwancin endoscopy, kasuwancin Sonoscape mai alaƙa da endoscopy har yanzu ya ɗan fi na Aohua girma. A shekarar 2024, kuɗaɗen shiga na kasuwanci da suka shafi endoscopy na Sonoscape da Aohua za su kai miliyan 800 da miliyan 750 bi da bi; dangane da ƙimar ci gaba, kasuwancin endoscopy na Sonoscape ya yi girma da sauri fiye da Aohua kafin 2022, amma tun daga 2023, saboda ƙaruwar yawan kayayyakin Aohua masu tsada, ƙimar ci gaban Aohua ta zarce ƙimar ci gaban kasuwancin endoscopy na Sonoscape.
Kwatanta kudin shigar aiki na Aohua da Sonoscape
(Ribar Yuan miliyan 100)
Kasuwar endoscope ta likitanci ta cikin gida tana da rinjayen samfuran da aka shigo da su daga ƙasashen waje. Masana'antun cikin gida waɗanda Sonoscape da Aohua ke wakilta suna ƙaruwa da sauri kuma a hankali suna maye gurbin shigo da kayayyaki daga ƙasashen waje. Kasuwancin cikin gida shine mafi mahimmancin fannin kasuwanci na Sonoscape da Aohua. A cikin 2024, kasuwancin cikin gida ya kai kashi 51.83% da 78.43% na yawan kasuwancin Sonoscape da Aohua bi da bi. A lokaci guda, manyan kamfanonin cikin gida waɗanda Sonoscape da Aohua ke wakilta suna tura kasuwannin ƙasashen waje a hankali, kuma yawan kasuwancin endoscope na likitanci na cikin gida a kasuwar duniya yana ci gaba da ƙaruwa.
Kasuwancin endoscope na duniya na Aohua yana ci gaba da ƙaruwa, daga Yuan miliyan 100 a shekarar 2020 zuwa Yuan miliyan 160 a shekarar 2024, amma hannun jarin kasuwancinta na duniya ya ragu daga kashi 36.8% a shekarar 2020 zuwa kashi 21.6% a shekarar 2024.
Kasuwancin likitanci na Sonoscape ya ƙunshi sassa da yawa, kuma tsarin kasuwancin endoscope na cikin gida da na ƙasashen waje ba a bayyana shi daban ba. Jimillar kasuwancin kamfanin a duniya yana ƙaruwa, daga Yuan miliyan 500 a shekarar 2020 zuwa Yuan miliyan 970 a shekarar 2024, kuma adadin kasuwancin ƙasashen duniya yana da daidaito, tsakanin kashi 43% zuwa 48%.
Kwatanta harkokin kasuwancin ƙasashen duniya da Aohua da Sonoscape suka buɗe
(Ribar Yuan miliyan 100)
Kason kasuwancin ƙasashen duniya da Aohua da Sonoscape suka buɗe
Matsayin riba
A matsayin manyan kamfanoni biyu na likitancin cikin gida masu suna Flexible endoscopes, Aohua da Sonoscape sun ci gaba da samun riba mai yawa tare da samfuransu masu inganci da damar kasuwanci. Jimlar ribar Aohua ta karu a hankali daga 67.4% a 2020 zuwa 73.8% a 2023, amma zai ragu zuwa 68.2% a 2024; Jimlar ribar Sonoscape ta karu a hankali daga 66.5% a 2020 zuwa 69.4% a 2023, amma zai ragu zuwa 63.8% a 2024; Jimlar ribar Sonoscape ta ragu kadan fiye da na Aohua, amma galibi saboda bambance-bambancen tsarin kasuwanci ne. Idan aka yi la'akari da kasuwancin endoscopy kawai, jimillar ribar da Sonoscape ke samu ta karu daga kashi 65.5% a shekarar 2020 zuwa kashi 74.4% a shekarar 2023, amma zai ragu zuwa kashi 66.6% a shekarar 2024. Jimlar ribar da kamfanonin endoscopy guda biyu ke samu iri daya ne.
Kwatanta jimillar ribar da ke tsakanin Aohua da Sonoscape
Zuba jari a fannin bincike da ci gaba (R&D)
Aohua da Sonoscape suna ba da muhimmanci sosai ga bincike da haɓaka samfura. Kuɗin bincike da haɓaka samfura na Aohua ya karu daga kashi 11.7% a shekarar 2017 zuwa kashi 21.8% a shekarar 2024. Kuɗin bincike da haɓaka samfura na Sonoscape ya kasance tsakanin kashi 18% zuwa 20% a cikin 'yan shekarun nan, amma a shekarar 2024, an ƙara yawan jarin bincike da haɓaka samfura, wanda ya kai kashi 23.5%.
Kwatanta kashe kuɗin bincike da ci gaban fasaha tsakanin Aohua da Sonoscape (yuan miliyan)
Kwatanta jarin ma'aikatan bincike da ci gaba tsakanin Aohua da Sonoscape
Aohua da Sonoscape suna ba da muhimmanci sosai ga saka hannun jari a fannin ma'aikatan bincike da ci gaba. A cikin 'yan shekarun nan, rabon ma'aikatan bincike da ci gaba na Kaili ya kasance daidai da kashi 24%-27% na jimillar ma'aikata, yayin da rabon ma'aikatan bincike da ci gaba na Aohua ya kasance daidai da kashi 18%-24% na jimillar ma'aikata.
Mu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., kamfani ne da ke kera kayayyaki a China wanda ya ƙware a fannin amfani da endoscopic, kamar suƙarfin biops, hemoclip, tarkon polyp, allurar sclerotherapy, feshi catheter, gogewar cytology, waya mai jagora, Kwandon ɗaukar dutse, catheter na magudanar ruwa ta hanci,rufin shiga ureteralkumarufin shiga ureteral tare da tsotsada sauransu waɗanda ake amfani da su sosai a cikinEMR, ESD, ERCPKayayyakinmu an ba su takardar shaidar CE, kuma masana'antunmu an ba su takardar shaidar ISO. An fitar da kayayyakinmu zuwa Turai, Arewacin Amurka, Gabas ta Tsakiya da wani ɓangare na Asiya, kuma yana sa abokin ciniki ya yaba da kuma yaba masa sosai!
Lokacin Saƙo: Yuli-14-2025